The impact of hemoglobin level and transfusion on the outcomes of chemotherapy in gastric cancer patients.

Abstract

Low nadir Hb (<90 g/L) during chemotherapy had an effect on the survival and chemotherapy response rate. The chemotherapy outcomes could not be improved through increasing Hb level by red blood cell (RBC) transfusion.